COVID-19 Vaccine
STI-1499, a Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability to Completely Inhibit In Vitro Virus Infection in Preclinical Studies
Sorrento Therapeutics, Inc.
PR-M05-20-NI-028May 18, 2020
Obesity
Kintai Therapeutics Advances Anti-Obesity Agent After Demonstrating Sustained Weight Loss
Kintai Therapeutics
PR-M01-20-NI-039Jan 28, 2020
Preclinical Results
NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate
NeuClone Pty. Ltd
PR-M05-18-NI-052May 14, 2018